Aktuella utlysningar, vecka 38, 2017
Grants Office tipsar om aktuella utlysningar
Svenska och nordiska anslag
Neuro Association | Neuroförbundet
Stöder medicinskt forsknings- och utvecklingsarbete om neurologiska sjukdomar samt socialt och beteendevetenskapligt forsknings- och utvecklingsarbete inom området.
Closing date: 29 Sep 2017
ERC-2018-PoC proof of concept grants - Horizon 2020: Excellent Science, EU
These aim to maximise the value of ERC-funded research by funding further work to verify the innovation potential of ideas arising from ERC funded projects. The total budget is €20 million to fund an estimated 130 projects. Grants are worth up to €150,000 each over up to 18 months.
Closing date: 16 Jan 2018
Susanne Klein-Vogelbach prize for the research of human movement - Georg and Susanne Klein Vogelbach Foundation
The Georg and Susanne Klein-Vogelbach Foundation invites applications for the Susanne Klein-Vogelbach prize for the research of human movement. This recognises researchers in neuroscience, orthopaedics and associated sciences which is oriented to establish a better understanding of the underlying principles of human movement and its rehabilitation, meaning all kinds of muscular-induced human movement, including mime and music.
Closing date: 10 Oct 2017
Dr HP Heineken prize for biochemistry and biophysics - Royal Netherlands Academy of Arts and Sciences (KNAW) | Koninklijke Nederlandse Akademie van Wetenschappen
The Royal Netherlands Academy of Arts and Sciences (KNAW) invites nominations for the Dr HP Heineken prize for biochemistry and biophysics. This recognises outstanding research in biochemistry and biophysics. Internationally renowned researchers in biochemistry or biophysics whose research still holds considerable promise for future innovative discoveries may be nominated.
Closing date: 15 Oct 2017
The Royal Netherlands Academy of Arts and Sciences (KNAW) invites nominations for the Dr AH Heineken prize for medicine. This recognises pioneering work in medical research. Internationally renowned medical researchers whose research holds promise for future innovative discoveries may be nominated.
Closing date: 15 Oct 2017
JUST-2017-AG-DRUG supporting initiatives in the field of drugs policy - Directorate-General for Justice
The Directorate-General for Justice invites proposals for the JUST-2017-AG-DRUG call supporting initiatives in the field of drugs policy. This call supports projects in the field of drugs policy in regards to judicial cooperation and crime prevention. Priority is given to supporting:
- Activities in the area of identification and epidemiology of use of new psychoactive substances;
- Activities aimed at the effective response to the challenges posed by the online trade of drugs;
- Civil society organisations by reinforcing their advocacy function, capacity to make a difference at the local level, best practice sharing methods and knowledge and skills on evidence-based interventions and minimum quality standards in the field of drug demand reduction;
- Key stakeholders in the field of prevention by expanding their knowledge and skills, in particular in the context of minimum quality standards.
Closing date: 15 Oct 2017
Federal Funding agencies
Innovative Approaches or Technologies to Investigate Regional, Structural and Functional Heterogeneity of CNS Small Blood and Lymphatic Vessels (R01) -NIH
This Funding Opportunity Announcement (FOA) will solicit research projects focused on the development of new technology and tools, or novel mechanistic studies, or a combination of mechanistic and technology development studies specific to central nervous system (CNS, which includes retina) small blood and lymphatic vessels in health and disease, across the life span. The program aims at facilitating the development of tools and technology to image, profile and map CNS small blood and lymphatic vessels. Additional goals are to elucidate the mechanisms underlying CNS small blood and lymphatic vessels structural and functional heterogeneity, differential susceptibility to injury, role in disease and repair processes, and their responses to therapies. Preclinical studies using in vitro and/or animal models specific to CNS small blood and lymphatic vessels alone or in combination with pilot human studies are appropriate for this FOA.
Closing dates: Dec11, 2017, by 5:00 PM local time of applicant organization.
Human Studies of Target Identification, Biomarkers and Disease Mechanisms Specific to CNS Small Blood and Lymphatic Vessels (R01) -NIH
This Funding Opportunity Announcement (FOA) will solicit research projects to facilitate the development and translation of tools and technology for non-invasive imaging and profiling of human central nervous system (CNS, including retina) small blood and lymphatic vessels; to investigate their role in CNS physiology, disease, repair processes, and responses to therapy using novel approaches. Applications can be focused on the development of new technology and tools, novel target or biomarker identification and validation studies, or a combination of mechanistic and technology development studies specific to human CNS small blood and lymphatic vessels in health and disease, across the life span.
Closing dates: Dec 11, 2017, by 5:00 PM local time of applicant organization.
Angelman syndrome call for proposals — Angelman Syndrome Foundation
The Angelman Syndrome Foundation invites proposals for its research on Angelman syndrome grants. These support research in preclinical, translational and clinical areas that investigate all aspects of Angelman syndrome.
Priority will be given to pilot projects that test new ideas on the pathogenesis and therapy of the syndrome. Studies related to communication, behavioural issues and identification of issues and treatments that impact the daily lives of people with the disease and their families are of particular interest.
Closing dates: Applications due on every Oct 15 and April 15.
Alzheimer's Disease Research Grants— BrightFocus Foundation
The standard award provides significant funding for researchers who have already generated some amount of preliminary data, but are often required to demonstrate additional, significant progress before they can apply to governmental or industrial funding agencies.
Closing date: Oct 18, 2017 11:59 p.m. EST (Washington, D.C.)
Career Development Award for Pediatric Cancer Research— American Association for Cancer Research
The American Association for Cancer Research, in partnership with Aflac Inc, invites applications for its career development awards for paediatric cancer research. These support junior faculty in conducting paediatric cancer research and establishing successful career paths in this field. The research proposed for funding may be basic, translational, clinical or epidemiological in nature and must have direct applicability and relevance to paediatric cancer.
Closing dates: 10/18/2017 1:00:00 PM Eastern Standard Time.
QuadW Foundation-AACR Fellowship for Clinical/Translational Sarcoma Research— American Association for Cancer Research
The American Association for Cancer Research, in partnership with the QuadW Foundation, invites applications for its fellowship for clinical and translational sarcoma research. This supports a postdoctoral or clinical research fellow to conduct translational or clinical sarcoma research and to establish a successful career path in this field.
Closing date: 25 Oct 2017 1:00:00 PM Eastern Standard Time.
Prevention innovative grants— Juvenile Diabetes Research Foundation International
The Juvenile Diabetes Research Foundation International invites applications for its prevention innovative grants. These provide seed funding for innovative research projects with potential to accelerate the mission of the foundation on curing type 1 diabetes. Proposals should address key questions and have the potential to lead to a change in the current paradigm or conventional wisdom or lead to a groundbreaking discovery. Preliminary data is not required in the proposal but the underlying premise, goal, or hypothesis must be plausible and testable and the proposal must be focused with a well defined goal that is achievable within the timeframe of the award.
Closing date: 31 Oct 2017
Research grant programme – idea grants - Barth Syndrome Foundation
The Barth Syndrome Foundation, under the research grant programme, invites proposals for its idea grants. These support basic science and clinical research on the natural history, biochemical basis and treatment of Barth syndrome. Although any research proposal related to Barth syndrome is considered, the following areas are of particular interest:
•mechanism of neutropenia in Barth syndrome;
•gastrointestinal pathophysiology in Barth syndrome;
•search for compounds that may improve mitochondrial performance in Barth syndrome.
Closing date: 31 Oct 2017